These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 4021280)
1. [Mechanism of the anti-arrhythmic action of phosphocreatine in acute myocardial ischemia]. Rozenshtraukh LV; Saks VA; Aniukhovskiĭ EP; Beloshapko GG; Iushmanova Av Kardiologiia; 1985 Apr; 25(4):80-5. PubMed ID: 4021280 [TBL] [Abstract][Full Text] [Related]
2. The antiarrhythmic action of phosphocreatine in acute myocardial ischemia. Rosenshtraukh LV; Saks VA; Anyukhovsky EP; Beloshapko GG; Yushmanova AV Biochem Med; 1985 Aug; 34(1):120-8. PubMed ID: 4052059 [TBL] [Abstract][Full Text] [Related]
3. [Effect of phosphocreatine and phosphocreatinine on membrane phospholipid metabolism in acute myocardial ischemia]. Aniukhovskiĭ EP; Dzhavadov SA; Preobrazhenskiĭ AN; Beloshapko GG; Rozenshtraukh LV Kardiologiia; 1985 Aug; 25(8):64-8. PubMed ID: 4068466 [TBL] [Abstract][Full Text] [Related]
4. [Characteristics of the anti-arrhythmia effect of phosphocreatine in the acute stage of experimental myocardial infarction]. Kryzhanovskiĭ SA; Vititnova MB; Kaverina NV; Bobkov IuG; Saks VA Kardiologiia; 1988 Nov; 28(11):100-3. PubMed ID: 3230761 [TBL] [Abstract][Full Text] [Related]
5. Some mechanisms of nonspecific antiarrhythmic action of phosphocreatine in acute myocardial ischemia. Rosenshtraukh LV; Anyukhovsky EP; Beloshapko GG; Undrovinas AI; Fleidervish IA; Paju AY; Glukhovtsev EV Biochem Med Metab Biol; 1988 Dec; 40(3):225-36. PubMed ID: 3233180 [TBL] [Abstract][Full Text] [Related]
6. [Study of the nonspecific effect of phosphocreatine disodium salt on the process of excitation conduction in acute myocardial ischemia]. Rozenshtraukh LV; Fleĭdervish IA; Undrovinas AI; Paiu AIu Kardiologiia; 1988 Jun; 28(6):95-100. PubMed ID: 3204914 [TBL] [Abstract][Full Text] [Related]
7. [Electrophysiologic study of the anti-arrhythmic mechanism of action of phosphocreatine in acute myocardial ischemia and reperfusion]. Kryzhanovskiĭ SA; Kacharava VG; Marko R; Kelemen K; Kaverina NV; Sakhs VA Kardiologiia; 1991 Nov; 31(11):66-9. PubMed ID: 1805069 [TBL] [Abstract][Full Text] [Related]
8. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy]. Gülker H; Thale J Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the antiarrhythmic profile of the new class I agent diprafenone. Gülker H; Thale J; Olbing B; Heuer H; Frenking B; Bender F Arzneimittelforschung; 1985; 35(9):1387-93. PubMed ID: 4084340 [TBL] [Abstract][Full Text] [Related]
10. Effect of phosphocreatine and related compounds on the phospholipid metabolism of ischemic heart. Anyukhovsky EP; Javadov SA; Preobrazhensky AN; Beloshapko GG; Rosenshtraukh LV; Saks VA Biochem Med Metab Biol; 1986 Jun; 35(3):327-34. PubMed ID: 3718764 [TBL] [Abstract][Full Text] [Related]
11. [Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion]. Gülker H; Thale J; Brisse B; Bender F Z Kardiol; 1984 Aug; 73(8):515-24. PubMed ID: 6495811 [TBL] [Abstract][Full Text] [Related]
12. Protection of ischemic myocardium by exogenous phosphocreatine (neoton): pharmacokinetics of phosphocreatine, reduction of infarct size, stabilization of sarcolemma of ischemic cardiomyocytes, and antithrombotic action. Sharov VG; Afonskaya NI; Ruda MY; Cherpachenko NM; Pozin EYa ; Markosyan RA; Shepeleva II; Samarenko MB; Saks VA Biochem Med Metab Biol; 1986 Feb; 35(1):101-14. PubMed ID: 3778674 [TBL] [Abstract][Full Text] [Related]
17. [Utilization of anti-arrhythmic drugs]. Perrenoud JJ Schweiz Med Wochenschr; 1980 Jul; 110(29):1090-6. PubMed ID: 6999615 [TBL] [Abstract][Full Text] [Related]
18. Effects of verapamil and magnesium sulfate on electrophysiologic changes during acute myocardial ischemia and following reperfusion in dogs: comparative effects of administration by intravenous and coronary sinus retroperfusion routes. Yamamoto K; Bando S Angiology; 1996 Jun; 47(6):557-68. PubMed ID: 8678330 [TBL] [Abstract][Full Text] [Related]
19. [The anti-arrhythmic action of exogenous creatine phosphate and its effect on myocardial electrophysiological parameters in acute heart failure]. Khanina NIa; Savel'ev VA; Vikulova OV Eksp Klin Farmakol; 1993; 56(2):26-8. PubMed ID: 8348031 [TBL] [Abstract][Full Text] [Related]
20. [High specificity in the molecular mechanism of the protective action of phosphocreatine on the myocardium in ischemia]. Saks VA; Makhotina LA; Lakomkin VL; Shteĭnshneĭder AIa; Kapel'ko VI Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(2):42-50. PubMed ID: 3233154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]